Comprehensive Analysis of Maryland Qualified Research and Development Expenses and the Strategic Framework of the State R&D Tax Credit

Maryland Qualified Research and Development Expenses represent the specific costs incurred for research activities conducted within Maryland that meet federal eligibility standards under Internal Revenue Code Section 41. These expenditures serve as the foundational metric for calculating the state’s 10% incremental tax credit designed to reward businesses that expand their technological investment beyond historical levels.1

The detailed analysis of these expenses reveals a sophisticated legal architecture designed to synchronize Maryland’s fiscal policy with the high-tech demands of the 21st-century economy. Under the governing statute, Maryland Tax-General Article § 10-721, the state provides a pathway for businesses to recover a significant portion of their investment in innovation, provided those investments have a direct geographical nexus to the state’s labor and supply markets.2 Unlike the federal Research and Experimentation credit, which applies broadly to domestic activities, the Maryland program requires a strict localization of effort. The definition of Maryland Qualified Research and Development (QRD) expenses is inextricably linked to the federal definitions found in § 41(b) of the Internal Revenue Code (IRC), encompassing wages, supplies, and a portion of contract research costs.1 However, the state introduces a layer of administrative complexity through its mandatory certification process. Businesses do not simply claim these expenses on an annual return; they must first undergo a rigorous application process through the Maryland Department of Commerce by November 15 of the year following the taxable year.1 This requirement reflects the state’s need to manage a hard statutory cap on total credits—currently set at $12 million annually—which necessitates a proration mechanism when the program is oversubscribed, as it routinely is by the state’s burgeoning biotechnology and cybersecurity sectors.1

Statutory Foundations and the Federal Nexus

The Maryland Research and Development Tax Credit is anchored in Tax-General Article § 10-721, which provides the primary definitions and authority for the incentive program.2 The statute establishes that the purpose of the program is to foster increased research activities and expenditures within the state.2 To achieve this, the state adopts a “federal-first” approach, where the technical eligibility of an expense is determined by its compliance with federal law, specifically IRC § 41.

Alignment with Internal Revenue Code Section 41

The reliance on federal law ensures that Maryland taxpayers can leverage their existing federal tax compliance infrastructure when applying for state benefits. The statute defines “Maryland qualified research and development” as research that qualifies under IRC § 41(d) and is conducted within Maryland.2 Similarly, “Maryland qualified research and development expenses” are defined as those qualified expenses under IRC § 41(b) incurred for research performed in-state.2

This alignment means that the federal “Four-Part Test” is the de facto standard for Maryland eligibility. Every research project for which expenses are claimed must satisfy these criteria: the research must be intended to create a new or improved business component; it must be technological in nature; it must intend to eliminate technical uncertainty; and it must involve a process of experimentation.5 If an activity fails any of these federal tests, the associated costs are automatically disqualified from being considered Maryland Qualified Research and Development Expenses.

The Geographical Requirement

While the technical definition is federal, the geographic scope is strictly local. For an expense to be “Maryland-sourced,” the underlying activity must physically occur within the state’s borders.1 This creates a high burden of proof for companies with distributed workforces. Wages paid to an employee who performs research while working remotely from a neighboring state, such as Virginia or Delaware, generally cannot be included in the Maryland QRE calculation, even if the research supports a Maryland-based product.1 The Department of Commerce and the Comptroller emphasize that the location where services are performed and where supplies are consumed is the ultimate arbiter of eligibility.2

Classification of Eligible Expenses

Maryland Qualified Research and Development Expenses are categorized into four primary buckets, following the structure of the federal tax code but refined by state-level administrative releases and regulations.

Qualified Research Wages

Wages represent the largest component of most R&D claims. Under Maryland law, these include the Box 1 W-2 wages of employees who are directly engaged in qualified research, as well as those who provide direct supervision or direct support of such research.1

1. Direct Research: This encompasses the actual “hands-on” work of scientists, engineers, and software developers who are conducting the experimentation.1
2. Direct Supervision: This includes the immediate managers of the research staff who are involved in the technical direction of the projects. General management or executive oversight that is not technically focused does not qualify.1
3. Direct Support: This covers lab technicians, machinists, or other staff who assist in the research process, such as by cleaning lab equipment or building prototypes.1

The state requires meticulous time-tracking to justify the percentage of each employee’s salary allocated to R&D. If an employee spends less than 80% of their time on research, only the portion of their wages actually spent on R&D can be claimed. If they spend 80% or more, then 100% of their wages may be treated as Maryland QREs.1

Supplies and Materials

Maryland allows for the inclusion of costs for tangible property, other than land or improvements to real property, that is consumed in the research process.1 This typically includes chemicals, prototype materials, and laboratory supplies. Importantly, the supplies must be consumed in Maryland to be considered a Maryland Qualified Research and Development Expense.1 Equipment that has a useful life beyond the research project and is subject to depreciation is generally excluded from QREs, although it may qualify for other state incentives like the Sales and Use Tax Exemption for R&D.7

Contract Research Expenses

When a business hires a third party to perform research on its behalf, 65% of the amount paid is generally eligible as a Maryland QRE.1 If the research is performed by a qualified research consortium, such as a university, the rate increases to 75%.1 A critical compliance point in Maryland is that the business claiming the credit may not include expenses paid to a third-party vendor if that vendor is also claiming a credit for those same expenses.9 This prevents the “double-dipping” of incentives within the state’s innovation ecosystem.

Computer Rental and Leasing Costs

Expenses for the rental or leasing of computers used in qualified research are eligible. In the modern context, this frequently applies to cloud computing and hosting costs for software development environments.1 To be eligible, the cloud resources must be used specifically for research and experimentation rather than for general administrative or commercial operations.

The 2021 Legislative Redesign and the 10% Growth Model

The landscape of Maryland’s R&D tax incentives shifted dramatically following the passage of Senate Bill 196 in 2021.10 Historically, Maryland offered two distinct credits: a “Basic” credit of 3% for all expenses up to the base amount, and a “Growth” credit of 10% for expenses exceeding the base amount.6

Repeal of the Basic Credit

Effective for tax years beginning after December 31, 2020, the Basic credit was repealed.7 This was a strategic decision by the Maryland General Assembly to focus the state’s limited fiscal resources on “incremental” innovation—specifically rewarding companies that are expanding their research footprint rather than those maintaining a steady state of spending.7 Consequently, all references to the 3% Basic credit in contemporary calculations are purely for historical context or for those few taxpayers still processing carryforwards from prior years.7

Current Benefit Structure

The current program offers a single 10% credit for Maryland Qualified Research and Development Expenses that exceed a calculated base amount.1 This is known as an incremental credit because it does not apply to the total R&D spend, but only to the growth in spending.1

This 10% rate is one of the more generous state-level rates in the country, but the actual realized benefit is often lower due to the proration required by the $12 million statewide limit.1

Calculation Mechanics: Determining the Maryland Base Amount

The “Maryland Base Amount” is the most critical variable in the credit calculation, as it serves as the hurdle a company must clear to earn the 10% credit. The formula is designed to capture a company’s historical research intensity.1

The Fixed-Base Percentage

The calculation begins with the Fixed-Base Percentage. For a standard business, this is determined by taking the aggregate Maryland QREs for the four years preceding the credit year and dividing them by the aggregate Maryland gross receipts for those same four years.1

$$Fixed\ Base\ Percentage = \frac{\sum Maryland\ QREs\ (Prior\ 4\ Years)}{\sum Maryland\ Gross\ Receipts\ (Prior\ 4\ Years)}$$

If the business has not been in existence for four years, the calculation uses the number of years the business has been in operation.1

The Base Amount Formula

Once the percentage is established, the Maryland Base Amount is calculated by multiplying that percentage by the average annual Maryland gross receipts for the four preceding years.1

$$Base\ Amount = Fixed\ Base\ Percentage \times Average\ Annual\ Maryland\ Gross\ Receipts$$

For startups that have never incurred R&D expenses in Maryland before the credit year, the Maryland Base Amount is zero.1 This “Zero-Base” provision is highly advantageous for new tech firms, as it allows them to take the 10% credit on the entirety of their first-year qualified spending.1

Short Year Adjustments

Under COMAR 03.04.10.03, if a taxpayer has a short taxable year (less than 12 months), the base amount must be adjusted.13 The “Maryland adjusted base amount” is the base amount multiplied by a fraction representing the number of days in the short year divided by 365.3

$$Adjusted\ Base\ Amount = Base\ Amount \times \frac{Days\ in\ Tax\ Year}{365}$$

This ensures that the threshold for growth is scaled to the length of the reporting period, preventing businesses from being penalized for truncated fiscal years.13

Small Business Relief and Refundability

Maryland provides a significant “equity” mechanism within the R&D tax credit program specifically for small businesses. Because many innovative startups are in a “pre-revenue” or “loss-making” phase, a non-refundable tax credit that only offsets future liability would be of little immediate value.1

Qualifying as a Small Business

A business is classified as a “small business” if it is a for-profit entity with net book value assets of less than $5 million at either the beginning or the end of the taxable year for which the expenses were incurred.1 The term “net book value assets” refers to total assets—including intangibles like patents—minus depreciation and amortization, but without subtracting liabilities.1

Refundability and the $3.5 Million Set-Aside

For companies meeting the small business definition, the credit is fully refundable.1 If the certified credit amount exceeds the small business’s Maryland income tax liability, the state will issue a refund check for the difference. This provides a direct cash infusion that can be reinvested into further research.1

Furthermore, the state reserves $3.5 million of the $12 million annual cap exclusively for small businesses.1 If this set-aside is not fully utilized, the remainder is reallocated to the general business pool. If, however, small business applications exceed $3.5 million, they are prorated separately from the larger companies, often resulting in a higher effective credit rate for smaller firms.3

Local State Revenue Office Guidance and Administrative Procedures

The administration of the Maryland R&D tax credit is shared between the Maryland Department of Commerce and the Comptroller of Maryland. This dual-agency oversight requires taxpayers to follow a specific timeline and set of documentation standards.

The Certification Cycle

The Maryland Department of Commerce is responsible for the application and certification phase. Businesses do not claim the credit on their original tax return for the year the expenses were incurred.1

1. Application: A business must submit an online application to the Department of Commerce by November 15 of the calendar year following the tax year in which the expenses were incurred.1
2. Certification: The Department reviews the applications and calculates the proration based on the total pool of requests. By February 15 of the following year, the Department issues a “Certification Letter” stating the approved credit amount.1
3. Claiming the Credit: After receiving the letter, the taxpayer may claim the credit on an amended tax return for the year the expenses were incurred or on any return filed within the next seven years.1

Guidance for Pass-Through Entities (PTEs)

For partnerships, S-corporations, and LLCs, the credit is calculated and certified at the entity level.1 The credit then flows through to the individual members (partners, shareholders) based on their distributive share of the business.1

Administrative Release No. 42 provides guidance for PTE members receiving these credits, emphasizing that the member must provide the entity’s Federal Employer Identification Number (FEIN) on their personal return to ensure the credit is not disallowed by the Comptroller.15 For “Electing PTEs” that pay tax at the entity level under Senate Bill 496, the credit can be applied directly against the entity-level tax on Form 511.16

Documentation and Audit Standards

The Comptroller of Maryland advises taxpayers to maintain comprehensive records for at least four years to defend against potential audits.1 Guidance suggests that simple accounting records are insufficient; taxpayers must provide technical evidence of the research activity.

• Project Descriptions: Detailed narratives for each project, explaining the technical goals and the uncertainties encountered.1
• Wages and Time Records: W-2s, payroll registers, and time logs or percentage-of-time allocations for every employee included in the claim.1
• General Ledger Detail: Invoices and receipts for supplies and contract research payments.1
• Federal Alignment: A copy of Federal Form 6765 (Credit for Increasing Research Activities) if the business also claimed the federal credit.9

Comprehensive Calculation Example: BioTech Innovations, Inc.

To illustrate the application of Maryland Qualified Research and Development Expenses in a real-world scenario, we examine “BioTech Innovations, Inc.,” a hypothetical mid-sized biotechnology firm based in Rockville.

Scenario 1: Standard Calculation and Proration

BioTech Innovations is not a small business, as its net book value assets are $15 million. In 2024, the company incurred $5,000,000 in Maryland Qualified Research and Development Expenses.1

Historical Data (2020-2023):

Step 1: Calculate the Fixed-Base Percentage

$$Fixed\ Base\ Percentage = \frac{\$15,000,000}{\$55,000,000} \approx 27.27\%$$

1

Step 2: Calculate Average Annual Gross Receipts (Prior 4 Years)

$$Average\ Gross\ Receipts = \frac{\$55,000,000}{4} = \$13,750,000$$

1

Step 3: Calculate the Maryland Base Amount

$$Base\ Amount = 27.27\% \times \$13,750,000 \approx \$3,749,625$$

1

Step 4: Calculate the Gross Growth Credit

The credit is 10% of the QREs in excess of the base amount.1

$$Excess\ QREs = \$5,000,000 – \$3,749,625 = \$1,250,375$$

$$Gross\ Growth\ Credit = \$1,250,375 \times 0.10 = \$125,037.50$$

1

Step 5: Apply Proration

The company submits its application by November 15, 2025. In February 2026, the Department of Commerce informs the company that the $8.5 million pool for large businesses was oversubscribed, with a total of $17 million in requests. The proration factor is 0.50.3

$$Certified\ Credit = \$125,037.50 \times 0.50 = \$62,518.75$$

Scenario 2: Startup Calculation

If BioTech Innovations were a startup in its first year of operation (2024), its Maryland Base Amount would be $0.

$$Gross\ Growth\ Credit = \$5,000,000 \times 0.10 = \$500,000$$

However, the state imposes a per-applicant maximum of $250,000.1

$$Final\ Requested\ Credit = \$250,000$$

Even after proration (assuming 0.50), the company would receive $125,000.1

Statistical Insights and Economic Evaluation (2024 DLS Report)

The 2024 evaluation by the Department of Legislative Services (DLS) provides critical statistical context on the impact of Maryland Qualified Research and Development Expenses on the state’s economy.7

R&D Growth Trends

The DLS report highlights a significant gap between Maryland’s R&D output and the national average. Despite the tax credit, Maryland’s business-funded R&D expenditures grew by only 61% from 2015 to 2021, compared to an 84% growth rate nationwide.7 This suggests that while the credit is a valuable incentive for individual firms, it has not yet catalyzed a level of state-wide innovation that outpaces national trends.7

Utilization and Fiscal Impact

The program is highly concentrated in specific sectors. Biotechnology and technology companies are the primary users, frequently exhausting the full $12 million annual cap.1

The DLS report also noted that most credits (approximately 80-90%) are claimed against corporate income tax, which has a ripple effect on local revenues. Specifically, the credit reduces the state income tax collections that fund the Highway User Revenues (HUR) by an estimated $200,000 to $300,000 annually.7

Participation and Concentration

A key objective of the 2021 redesign was to reduce the concentration of awards among the largest firms. The DLS found that the changes successfully increased the share of credits going to small businesses and diversified the pool of industries participating in the program.7 However, participation in terms of the number of distinct businesses has seen a slight decline in recent years, which may be attributed to the increased administrative burden of the growth-only model.7

Interactions with Corporate Structuring: Mergers and Controlled Groups

The definition and calculation of Maryland Qualified Research and Development Expenses are significantly impacted by corporate transactions. Maryland follows the federal guidelines under IRC § 41(f) to prevent the artificial creation of credits through corporate maneuvering.1

The Controlled Group Rule

All members of a controlled group of corporations—as defined by federal law—are treated as a single taxpayer for the purposes of the Maryland R&D tax credit.1 This means the group must aggregate all Maryland QREs and all Maryland gross receipts from every subsidiary to calculate one group-wide Fixed-Base Percentage and one Base Amount.3

The resulting credit is then allocated among the members based on each entity’s share of the total Maryland QREs.3 This prevents a parent company from moving research activities between subsidiaries to manipulate the base amount and maximize the 10% growth credit.1

Acquisitions and Dispositions

In a merger or acquisition, the treatment of historical R&D data is vital. If Company A acquires Company B, it must include Company B’s historical Maryland QREs and Maryland gross receipts in its own base amount calculation moving forward.1

• Stock Purchase: If the transaction is a stock purchase, the unused R&D tax credit carryforwards of the acquired company generally stay with the surviving entity and can be used to offset future Maryland tax liability.1
• Asset Purchase: If the transaction is an asset purchase, the unused credits typically remain with the seller, as the corporate entity that earned and was certified for the credits continues to exist as the legal owner of those tax assets.1

Comparison with Concurrent Maryland Incentives

The R&D tax credit is one of several tools used by Maryland to support its innovation economy. Strategic tax planning often involves coordinating the R&D credit with other localized incentives.

The Sales and Use Tax Exemption for R&D

Perhaps the most significant companion to the income tax credit is the Sales and Use Tax Exemption for R&D. This exemption allows businesses to purchase equipment, machinery, and software for use in research and development without paying the 6% state sales tax.7 The DLS 2024 report noted that this exemption likely has a greater impact on state revenues and business attraction than the income tax credit, as it provides an immediate 6% discount on capital expenditures without the uncertainty of proration or a multi-year carryforward period.7

The Biotechnology Investment Incentive Tax Credit (BIITC)

The BIITC is a refundable credit for investors who put money into “Qualified Maryland Biotechnology Companies”.10 While the R&D credit supports the operational expense of research, the BIITC supports the capital formation necessary to fund that research. In 2021, the BIITC was also modified to reduce its percentage value, reflecting a broader state-wide trend toward tightening incentive criteria.10

Income Tax Benefit Transfer Program (2025 Proposed Legislation)

Recent legislative proposals, such as HB 35 in 2025, suggest the creation of a program that would allow technology companies to sell their unused Maryland R&D tax credits and Net Operating Losses (NOLs) to other Maryland taxpayers.18 If passed, this would dramatically increase the value of the credit for large companies that currently have substantial credits trapped in a 7-year carryforward cycle due to a lack of immediate tax liability.18

Future Outlook and Sunset Provisions

The Maryland Research and Development Tax Credit is not a permanent fixture of the state tax code. It is subject to periodic review and reauthorization by the Maryland General Assembly.

The 2027 Sunset Date

The program is currently authorized through June 30, 2027.1 This means that unless the General Assembly acts to extend the statute, expenses incurred after this date will no longer be eligible for the credit. The 2024 DLS evaluation, which suggested the Assembly consider terminating the program in favor of more efficient incentives, may play a significant role in the upcoming debates regarding the program’s extension.7

Strategic Considerations for Taxpayers

As the program approaches its sunset date and faces potential reform, Maryland businesses should focus on the following strategic priorities:

1. Meticulous Sourcing: Ensure that all research activities are clearly documented as being “conducted in Maryland.” This is especially critical for remote-heavy engineering teams.1
2. Base Amount Management: Understand how current year spending will impact the base amount for the next four years. In an incremental model, a massive spike in R&D spending today creates a significantly higher hurdle for earning credits tomorrow.1
3. Small Business Status: Monitor the $5 million net book value asset threshold closely. Crossing this threshold transitions a company from a “refundable” cash benefit to a “non-refundable” tax asset, which can have significant implications for valuations and funding rounds.1
4. Audit Preparedness: Given the DLS report’s findings on the program’s underperformance, it is possible that the Comptroller’s office will increase the frequency and depth of R&D audits to ensure only the highest-quality research is being subsidized.1

Conclusion: The Role of Maryland QRD Expenses in Corporate Strategy

Maryland Qualified Research and Development Expenses are more than just line items in a tax calculation; they represent a company’s commitment to the state’s high-tech ecosystem. The 10% Growth R&D Tax Credit serves as a vital reward for businesses that are not only innovating but are doing so with an increasing intensity year-over-year. While the program’s structural complexities—including the 2021 repeal of the Basic credit, the $12 million aggregate cap, and the nuances of the “net book value” definition—present challenges for tax departments, the benefit remains a cornerstone of Maryland’s economic development strategy.1

For the professional peer group of tax directors, CFOs, and economic development advisors, the key takeaway is that the Maryland R&D credit is a “lagging” incentive. The work performed today must be meticulously tracked and then certified through a separate administrative process before it can ever appear on a tax return. In an environment where state resources are capped and competition for credits is fierce, the quality of a company’s documentation and its understanding of the “Maryland-conducted” nexus are the primary determinants of success in capturing this valuable state benefit.1

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/